Breast carcinoma detection with a combination of radiolabeled monoclonal antibodies: Promising results from immunohistochemistry studies

Cancer

Volumn 78, Issue 11, 1996, Pages 2334-2339

  Mangili, Francesca ^a,b   Sassi, Isabella ^a   Di Rocco, Mariagrazia ^a   Leone, Biagio Eugenio ^a   Garancini, Paola ^a   Santambrogio, Graziella ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Anat Patologica Ist Sci M S R   (Italy)

Author keywords

breast carcinoma; c erb B 2 protein; carcinoembryonic antigen; metastases; radiolabeled monoclonal antibodies; TAG 72

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; IODINE 125; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B.72.3; ONCOPROTEIN; TUMOR ANTIGEN;

ARTICLE; BREAST CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCINTIGRAPHY;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; GLYCOPROTEINS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM PROTEINS; RECEPTOR, ERBB-2;

EID: 0029806420     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961201)78:11<2334::AID-CNCR10>3.0.CO;2-1     Document Type: Article

References (33)

1. Baruggi GL. Radioimmunodetection of cancer. J Nucl Med All Sci 1985;29:261-7.
2. Mangili F, Stella M, Sassi I, Ferrara F, Paganelli G, De Nardi P, et al. Localization of biotinylated monoclonal antibodies (B72.3 and F023C5) in patients with colorectal cancer. Eur J Histochem 1993;37:53-7.
3. Chatal JF, Fumoleau P, Saccavini JC, Thedrez P, Curtet C, Bianco-Arco A, et al. Immunoscintigraphy of recurrences of gynecologic carcinomas. J Nucl Med 1987;28:1807-19.
4. Larson SM. Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy. J Nucl Med 1985;26:538-45.
5. Martin EW, Mojzisik M, Hinkle GH, Sampsel J, Siddiqi MA, Tuttle SE, et al. Radioimmunoguided surgery using monoclonal antibody. Am J Surg 1988;156:386-92.
6. Lamki LM, Buzdar AU, Singletary E, Rosenblum MG, Bhadkamkar V, Esparza L, et al. Indium-11 labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study. J Nucl Med 1991;32:1326-32.
7. Paganelli G, Magnani P, Zito F, Villa E, Sudati F, Lopalco L, et al. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res 1991;51:5960-6.
8. Histological typing of breast tumours. 2nd ed. Geneva: World Health Organization, 1981.
9. Hermanek P, Sabin LH. Classification of malignant tumours. 4th ed. 2nd rev. Springer-Verlag, 1992:103.
10. Paganelli G, Stella M, Zito F, Magnani P, De Nardi P, Mangili F, et al. Radioimmunoguided surgery using iodine-125-labeled biotinylated monoclonal antibodies and cold avidin. J Nucl Med 1994;35(12):1970-5.
11. Schlom J. Basic principles and applications of monoclonal antibodies in the management of carcinomas: THE Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1986;46:3225-38.
12. Natali PG, Nicotra MR, Bigotti A, Venturo I, Slamon DJ, Fendly BM, et al. Expression of the p185 encoded by HER-2 oncogene in normal and transformed human tissue. Int J Cancer 1990;45:457-61.
13. Schimmelpenning H, Erikson ET, Falkmer UG, Rutqvist LE, Johanson H, Fallenius A, et al. Prognostic significance of immunohistochemical C-erb b2 proto-oncogene expression and nuclear DNA content in human breast cancer. Eur J Surg Oncol 1992;18:530-7.
14. Molina R, Ciocca DR, Tandon AK, Allred DC, Clark GM, Chammes GC, et al. Expression of HER 2-neu oncoprotein in human breast cancer: a comparison of immunohistochemical and Western blot techniques. Anticancer Res 1992;12:1965-72.
15. Ferrara F, De Santis L, Mangili F, Sassi I, Luchini S, Mandelli C, et al. Role of DNA ploidy and erb-B2 oncogene expression in the prognosis of endometrial carcinoma. Pathol Res Pract 1994;190:1039-43.
16. Oredipe OA, Barth RF, Tuttle SE, Adams DM, Sautins I, Bucci DM, et al. Limits of sensitivity for the radioimmunodetection of colon cancer by means of a hand held gamma probe. Nucl Med Biol 1988;15:595-603.
17. Majiuri ML, Hakkarainen M, Paavonen T, Renkonen R. Carcinoembryonic antigen is expressed on endothelial cells. a putative mediator of tumor cell extravasation and metastasis. APMIS 1994;102:432-8.
18. Pignatelli M, Cardillo MR, Hanby A, Stamp GWH. Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors. Hum Pathol 1992;23:1159-66.
19. Siccardi AG, Buraggi GL, Callegaro L, Centi Colella A, De Filippi PG, Galli G, et al. Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab′)2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicentric study. Cancer Res 1989;49:3095-103.
20. Esteban JM, Felder B, Ahn C, Simpson JF, Battifora H, Shively JE. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients. Cancer 1994;74:1575-83.
21. Alexiev BA, Valkov IN, Popov AA, Marinov VS. Immunocytochemical detection of carcinoembryonic antigen in fine-needle aspirates from patients with diverse breast diseases. Diagn Cytopathol 1993;9:377-82.
22. Thor A, Noriaki O, Spatz CA, Johnston WW, Schlom J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 denned by monoclonal antibody B72.3. Cancer Res 1986;46:3118-24.
23. Soomro S, Shousha A. Monoclonal antibody B72.3 immunostaining of breast carcinoma. Arch Pathol Lab Med 1992;116:32-5.
24. Prey MU, Bedrossian CWM, Masood S. The value of monoclonal antibody B72.3 for the diagnosis of breast carcinoma: experience with the first commercially available source. Hum Pathol 1991;22:598-602.
25. Umekita Y, Enokizono N, Sagara Y, Kuriwaki K, Takasaki T, Yoshida A, et al. Immunohistochemical studies on oncogene products (EGF-R, c-erbB2) ANF growth factors (EGF, TGF-alfa) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status. Virchows Arch A Pathol Anat Histopathol 1992; 420:345-51.
26. Osaki A, Toi M, Yamada H, Kawami H, Ku roi K, Toge T. Prognostic significance of co-expression of c-erbB2 oncoprotein and epidermal growth factor receptor in breast cancer patients. Am j Surg 1992; 164:323-6.
27. Anderson TJ. c-erbB2 oncogene in breast cancer: theright target or a decoy? Hum Pathol 1992;23:971-3.
28. Barnes DM, Lammie GA, Millis RR, Gullick WL, Allen DS, Altman DG. An immunohistochemical evaluation of c-erbB2 expression in human breast carcinoma. Br J Cancer 1988;58:448-52.
29. McCann AH, Dervan PA, O'Regan M, Codd MB, Gullick WJ, Tobin BMJ, et al. Prognostic significance of c-erbB2 and estrogen receptor status in human breast cancer. Cancer Res 1991;51:3296-303.
30. Dittadi R, Donisi PM, Brazzale A, Marconato R, Spina M, Gion M. Immunoenzymatic assay of erbB2 protein in cancer and non-malignant breast tissue. Relationships with clinical and biochemical parameters. Anticancer Res 1992;12:2005-10.
31. Li BDL, Bauer KD, Carney WP, Duda RB. Detection of c-erbB2 oncoprotein expression in breast tissue by multiparameter flow cytometry. J Surg Res 1993;54:179-88.
32. Makar A, Desmedt EJ, De Potter CR, Vanderheyden JS, Schatteman EA. Neu (C-erbB2) oncogene in breast cancer and its possible association with the risk of distant metastases. Acta Oncol 1990;29:931-4.
33. Bacus SS, Bacus JW, Slamon DJ, Press MF. HER-2/neu oncogene expression and dna ploidy analysis in breast cancer. Arch Pathol Lab Med 1990;114:164-9.